Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control

Inclusion Criteria: * T2 insulin naïve patients * Patients whom their physician is considering initiation of Lantus treatment * Poor glycemic control 7,5 %10 % * T2 treatment with OADs more than 3 months * BMI\<40 kg/m2 Exclusion Criteria: * Impaired renal function (Cr\>2mg/dl or current renal dialysis) * Acute or chronic metabolic acidosis * Active liver disease or serum ALT or AST \>2,5 than normal * History of hypoglycemia unawareness * Diabetic retinopathy with surgery in the previous 3 months or planned within 3 months after study entry * Pregnancy, breast feeding The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.